Prophylactic etanercept treatment in cisplatin ototoxicity
- 228 Downloads
The aim of our study was to evaluate the audiological protective effects of etanercept using distortion product otoacoustic emission (DPOAE) in rats with hearing loss due to cisplatin ototoxicity. The study began with 36 healthy female albino rats; 31 rats had good measurements in DPOAE and were included in the study. On day 0, a single dose of etanercept was given by intraperitoneal administration to 15 rats (etanercept group). No medication was given to the control group. After 24 h, 16 mg/kg cisplatin was given to all rats. DPOAE measurements were performed on the 3rd, 7th, and 21st day. After the DPOAE test on the 21st day, the animals were killed by decapitation. Between-group and intra-group comparisons were made using the data of the two groups. A statistically significant difference was observed on the 3rd day at 4921 Hz and higher frequencies, on the 7th day at 6064 Hz and higher frequencies, and on the 21st day at 6494 Hz and higher frequencies (p < 0.05). We observed 10% ototoxicity in the etanercept group and 56% ototoxicity in the control group. A single dose of etanercept 1 day before cisplatin administration decreases cisplatin ototoxicity in the early period. This effect comes to the fore especially over 4500 Hz frequencies at 65 dB and higher.
KeywordsEtanercept Cisplatin Ototoxicity Otoacoustic emissions
Compliance with ethical standards
This study was funded by the Kocaeli University Scientific Research Projects Coordination Unit (Project Number: 2014143HDP).
All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. Project Number: 2014/35 KOU HADYEK 7/2-2014.
Conflict of interest
All the authors declare no conflict of interest.
- 2.Chirtes F, Albu S (2014) Prevention and restoration of hearing loss associated with use of cisplatin. Hindawi Publ Corp Biomed Res Int 2014:925485Google Scholar
- 3.So H, Kim H, Lee JH, Park C, Kim Y, Kim E, Kim JK, Yun KJ, Lee KM, Lee HY, Moon SK, Lim DJ, Park R (2007) Cisplatin cytotoxicity of auditory cells requires secretions of proinflammatory cytokines via activation of ERK and NF-kappaB. J Assoc Res Otolaryngol 8(3):338–355CrossRefPubMedPubMedCentralGoogle Scholar
- 25.Scherer EQ, Yang J, Canis M, Reimann K, Ivanov K, Diehl CD, Backx PH, Wier WG, Strieth S, Wangemann P, Voigtlaender-Bolz J, Lidington D, Bolz SS (2010) Tumor necrosis factor-α enhances microvascular tone and reduces blood flow in the cochlea via enhanced sphingosine-1-phosphate signaling. Stroke 41(11):2618–2624CrossRefPubMedPubMedCentralGoogle Scholar